Journals / Türkderm-Deri Hastalıkları ve Frengi Arşivi / 2014 / Cilt: 48 - Sayı: 4

Impact of obesity on disease severity in patients with plaque type psoriasis

Plak tip psoriasis hastalarında obezitenin hastalık şiddeti üzerine etkisi

Pages
193–196
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Although no effect of obesity on the severity of the disease was shown in our study, further controlled population based studies are needed to investigate the possible role of obesity in triggering and beginning of the disease. (Turkderm 2014; 48: 193-6)

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background and Design: Psoriasis is a chronic inflammatory systemic disease involving the skin, scalp, nails, and the joints and is characterized by periods of remission and exacerbation.
📊
Key Findings & Data:Results: When normal, overweight and obese psoriasis patients were compared, a statistically significant difference was not found in disease severity (p=0.707).
💡
Conclusion & Impact:Conclusion: Although no effect of obesity on the severity of the disease was shown in our study, further controlled population based studies are needed to investigate the possible role of obesity in triggering and beginning of the disease. (Turkderm 2014; 48: 193-6)
🔬Design:Research Article
📍Scope:2014 Verileri
⚙️Variables:Domain Parameters

Abstract

Background and Design: Psoriasis is a chronic inflammatory systemic disease involving the skin, scalp, nails, and the joints and is characterized by periods of remission and exacerbation. Although the pathogenesis of psoriasis is not fully understood, many genetic and environmental factors are believed to have a role in the development of the disease. Obesity, smoking, family history of psoriasis, repetitive physical traumas and major stress disorders are the factors thought to affect the severity and progress of the disease. In this study, we aimed to investigate the effects of obesity on the clinical severity of psoriasis in patients with chronic plaque psoriasis. Materials and Methods: Three hundred twenty-five outpatients with chronic plaque-type psoriasis were enrolled in the study. Body Mass ndex (BMI) and Psoriasis Area and Severity Index (PASI) values were recorded for each patient. Results: When normal, overweight and obese psoriasis patients were compared, a statistically significant difference was not found in disease severity (p=0.707). There was also no significant correlation between BMI and PASI values (r=0.006, p=0916). Conclusion: Although no effect of obesity on the severity of the disease was shown in our study, further controlled population based studies are needed to investigate the possible role of obesity in triggering and beginning of the disease. (Turkderm 2014; 48: 193-6)

Özet

Amaç: Psoriasis deri, saçlı deri, tırnak ve eklemleri tutan, aktivasyon ve remisyon periyodları ile karakterize kronik inflamatuvar sistemik bir hastalıktır. Psoriasis etyopatogenezi tam olarak açıklananamış olsa da birçok genetik ve çevresel faktörün hastalık gelişiminde rol oynadığı düşünülmektedir. Hastalığın seyri ve şiddetini etkileyen bu faktörler arasında tekrarlayan fiziksel travmalar, obezite, sigara içimi, ailede psoriasis öyküsü ve majör stres bozuklukları yer almaktadır. Bu çalışmada kronik plak psoriasisli hastalarda, obezitenin psoriasisin klinik şiddeti üzerine etkisinin araştırılması amaçlanmıştır. Gereç ve Yöntem: Çalışmaya kronik plak tip psoriasis tanısı alan 325 hasta alındı. Her bir hastanın Vücut Kitle İndeksi (VKİ) ve Psoriasis Alan Şiddet İndeksi (PAŞİ) değerleri kaydedildi. Hastaların VKİ değerleri ile psoriasis şiddeti ve PAŞİ skorları arasındaki ilişki araştırıldı. Bulgular: Psoriasisli normal, kilolu ve obez hastalar hastalık şiddeti açısından karşılaştırıldığında aralarında istatistiksel olarak anlamlı bir fark tespit edilmedi (p=0,707). Hastaların VKİ ve PAŞİ değerleri arasındaki korelasyon incelendiğinde de iki parametre arasında anlamlı bir korelasyon saptanmadı (r=0,006, p=0,916). Sonuç: Çalışmamızda, obezitenin her ne kadar hastalık şiddetine etkisi gösterilememişse de hastalığın tetiklenmesi ve başlangıcı üzerine olası etkisinin, sağlıklı kontrol grubu kullanılarak araştırılması gerektiğini söyleyebiliriz. (Türk­derm 2014; 48: 193-6)

🔖

Cite This Article

ÖZGÖZTAŞI, O., KAYIRAN, N., KORKMAZ, S. (2022). Impact of obesity on disease severity in patients with plaque type psoriasis. Türkderm-Deri Hastalıkları ve Frengi Arşivi, Cilt: 48 - Sayı: 4, 193–196. https://ajindex.com/articles/621847

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Gudjonsson JE, Elder JT: Psoriasis. Fitzpatrick's Dermatology in General Medicine. Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AM, Leffell DJ eds. 7th ed. New York, McGraw-Hill, 2008;169-93
  2. Griffiths CEM, Barker JNWN: Psoriasis. Rook’s Textbook of Dermatology. Burns T, Breathnach S, Cox N, Griffiths C. eds. 8th ed. Oxford, Wıley- Blackwell, 2010;20.1-20.54
  3. Van de Kerkhof PC: Psoriasis. Dermatology. Bolognia JL, Jorizzo JL, Rapini RP at al. eds. London, Mosby 2008:25-49
  4. Kundakci N, Türsen Ü, Babiker MOA, Gürgey E: The evaluation of the sociodemographic and clinical features of Turkish psoriasis patients. Int J Dermatol 2002;41:220-4
  5. Christophers E: Psoriasis-epidemiology and clinical spectrum. Clin Exp Dermatol 2001;26:314-20
  6. Gülekon A: Psoriasis ve benzeri dermatozlar. Dermatoloji. Tüzün Y, Gürer MA, Serveroğlu S, Sungur O, Aksungur LA (eds). 3’üncü baskı. İstanbul, Nobel Tıp Kitabevleri 2008;745-64
  7. Yazıcı AC, Karabulut AA: Psoriasisin genetik özellikleri ve patogenezi. Dermatose 2003;2:95-102
  8. Özdemir M, Okudan N, Gümüsel M, Gökbel H, Mevlitoglu İ: Serum leptin levels in patients with psoriasis vulgaris. T Klin J Dermatol 2006;16:98-101
  9. Gürer MA, Adışen E: Psoriasis, introduction, general information, epidemiology. Türkderm 2008;42:15-7
  10. Hinney A, Nguyen TT, Scherag A, et al: Genome wide association (GWA) study for early onset extreme obesity supports the role of fat mass and obesity associated gene (FTO) variants. PLoS One 2007;2:1361
  11. Herron MD, Hinckley M, Hoffman MS, et al: Impact of obesity and smoking on psoriasis presentation and management. Arch Dermatol 2005;141:1527-34
  12. Duarte GV, Follador I, Cavalheiro CM, Silva TS, Oliveira Mde F: Psoriasis and obesity: literature review and recommendations for management. An Bras Dermatol. 2010;85:355-60
  13. Hamminga EA, Van der Lely AJ, Neumann HA, Thio HB: Chronic inflammation in psoriasis and obesity: implications for therapy. Med Hypotheses 2006;67:768-73
  14. Arathi R.Setty, Curhan G, Choi HK: Smoking and the risk of psoriasis in women: Nurses' Health Study II. Am J Med 2007;120:953-9
  15. Naldi L, Chatenoud L, Linder D: Cigarette smoking, body mass index and stressful life events as risk faktors for psoriasis: results from an Italian case control study. J Invest Dermatol 2005;125:61-7
  16. Takahashi H, Tsuji H, Takahashi I, et al: Prevalence of obesity⁄adipozity in Japanese psoriasis patients: adipozity is correlated with the severity of psoriasis.